Announcements Trials

Browse Landscape

Phase

Status

Unknown 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Small Cell Lung Carcinoma 3 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Recurrence 1 Peritoneal Neoplasms 1 Neoplasm Metastasis 1 Nasopharyngeal Carcinoma 1 Liver, Cancer of, Primary Resectable 1 Hepatocellular Carcinoma Resectable 1 Head and Neck Neoplasms 1 Esophageal Neoplasms 1 Colorectal Neoplasms 1 Carcinoma, Hepatocellular 1 Breast Neoplasms 1 Advanced Gastric Cancer 1

Interventions

Fluorouracil 19 Oxaliplatin 17 Capecitabine 16 Leucovorin 14 Cisplatin 12 Irinotecan 11 Gemcitabine 11 Drug Therapy 11 Bevacizumab 10 pembrolizumab 9 Radiosurgery 9 Cetuximab 9 Docetaxel 8 Everolimus 7 spartalizumab 6 Sunitinib 6 Radiotherapy 6 Paclitaxel 6 Neoadjuvant Therapy 6 Cyclophosphamide 6 Trastuzumab 5 S 1 (combination) 5 Nivolumab 5 Immunotherapy 5 Immune Checkpoint Inhibitors 5 Chemotherapy, Adjuvant 5 Carboplatin 5 palbociclib 4 manganese chloride 4 Surgical Procedures, Operative 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Neoplasm Metastasis × lobaplatin × Clear all

NCT04808466 2022-02-21

WUHIPEC01

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Phase 2 Unknown

Gastrointestinal

Neoplasm Metastasis, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡